Tag Archives: Covaxin

Within 24 hours of last week, an expert committee from the national drug regulator changed its decision on whether Bharat Biotech’s Covid-19 candidate vaccine could be recommended for approval without evidence of its efficacy in humans, the minutes of the committee meetings held on January 1 and 2 show. The …

The head of Bharat Biotech expressed confidence in a press conference on Monday that Covaxin, the candidate vaccine developed by the company, will be effective in mutant strains of the new coronavirus, one of the main reasons approval has been granted for use restricted to candidate. The company will be …

KERALA HAS requested the Center to prioritize the distribution of Covid-19 vaccines, considering the high number of cases in the state and to make the most of its strategy of delaying the peak in the containment of the disease. Kerala Health Minister KK Shailaja said The Indian Express that the …

They advise against Covaxin, they say there is no evidence of efficacy. Several experts have raised concerns about the “rush approval” given to COVID-19 vaccines despite the lack of adequate efficacy data. The Central Drugs Standard Control Organization approved on Sunday the restricted emergency use of Oxford’s COVID-19 Covishield vaccine, …

Coronavirus Vaccine: Harsh Vardhan Slammed Opposition For His Comment On Vaccines New Delhi: Health Minister Harsh Vardhan criticized Congress and other opposition leaders for their comments on Bharat Biotech’s Covaxin, which was licensed for emergency use in the country along with the Oxford-AstraZeneca vaccine manufactured by the Serum Institute of …

NEW DELHI: With some Congressional leaders expressing concern over the granting of approval to Bharat Biotech’s Covid-19 vaccine, Union Health Minister Harsh Vardhan stated on Sunday that Covaxin is more likely to work against the newer variants of the virus, including the UK variant, and asked politicians not to “discredit …

Indicators are that Covaxin has very high efficacy, said ICMR (Representational) New Delhi: The Indian Council for Medical Research (ICMR) confirmed today that it had not received phase 3 efficacy or effectiveness data from one of the Covid vaccines that the government drug regulator authorized for emergency use. When specifically …

India has approved two COVID-19 vaccines – Covishield ‘from the Serum Institute of India and’ Covaxin ‘from Bharat Biotech – for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines should be given in two doses and should be stored at 2-8 ° C. Also read: Why people …

Covishield is set to “roll out in the next few weeks,” Adar Poonawalla said. (File photo) New Delhi: All the risks taken by the Serum Institute have finally paid off, tweeted Adar Poonawalla, CEO of the Pune-based vaccine manufacturer, shortly after the country’s drug regulator authorized its Covishield vaccine for …